Your browser doesn't support javascript.
loading
Cancer with low cathepsin D levels is susceptible to vacuolar (H+ )-ATPase inhibition.
Kitazawa, Satoshi; Nishizawa, Satoru; Nakagawa, Hideyuki; Funata, Masaaki; Nishimura, Kazuho; Soga, Tomoyoshi; Hara, Takahito.
Affiliation
  • Kitazawa S; Oncology Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.
  • Nishizawa S; Oncology Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.
  • Nakagawa H; Biomolecular Research Laboratories, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.
  • Funata M; Biomolecular Research Laboratories, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.
  • Nishimura K; Oncology Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.
  • Soga T; Institute for Advanced Biosciences, Keio University, Tsuruoka, Japan.
  • Hara T; Oncology Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.
Cancer Sci ; 108(6): 1185-1193, 2017 Jun.
Article in En | MEDLINE | ID: mdl-28317223
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cathepsin D / Vacuolar Proton-Translocating ATPases / Neoplasms Limits: Humans Language: En Journal: Cancer Sci Year: 2017 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cathepsin D / Vacuolar Proton-Translocating ATPases / Neoplasms Limits: Humans Language: En Journal: Cancer Sci Year: 2017 Type: Article Affiliation country: Japan